Mechanism-based inhibition of human cytochrome P450 1A1 by rhapontigenin

Drug Metabolism and Disposition

Volumn 29, Issue 4 I, 2001, Pages 389-393

  Chun, Young Jin ^a   Ryu, Shi Yong ^b   Jeong, Tae Cheon ^c   Kim, Mie Young ^a  

^a Chung Ang University   (South Korea)

^b Korea Research Institute of Chemical Technology   (South Korea)

^c Yeungnam University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTINEOPLASTIC AGENT; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; CYTOCHROME P450 2C8; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; DITHIOTHREITOL; ETHOXYRESORUFIN DEETHYLASE; GLUTATHIONE; RECOMBINANT ENZYME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; RHAPONTIGENIN; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL MEMBRANE; CANCER CHEMOTHERAPY; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SELECTIVITY; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; IC 50; LIVER MICROSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CYTOCHROME P-450 CYP1A1; ENZYME INHIBITORS; HUMANS; KINETICS; MICROSOMES, LIVER; NADP; RECOMBINANT PROTEINS; STILBENES;

BACTERIA (MICROORGANISMS);

EID: 0035064593     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: A series of substrates to distinguish between different induced cytochromes P-450
2. Anti-allergic action of resveratrol and related hydroxystilbenes
3. Resveratrol is a selective human cytochrome P450 1A1 inhibitor
4. Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodene
5. Analysis and characterization of enzymes
6. Characterization of rat and human liver microsomal cylochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism
7. Purification of functional recombinant P450s from bacteria
8. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes
9. 2-ethynyl-naphthalene as a mechanism-based inactivator of the cytochrome P-450 catalyzed N-oxidation of 2-naphthylamine
10. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin
11. Evaluation of the selectivity of in vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities
12. Mechanism-based cancer prevention approaches: Targets, examples, and the use of transgenic mice
13. Human dioxin-inducible cytochrome P1-450: Complementary DNA and amino acid sequence
14. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
15. Metabolic activation of aromatic amine mutagens by simultaneous expression of human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and N-acetyltransferase in Escherichia coli
16. Inactivation of cytochrome P450 2E1 by tert-butylisothiocyanate
17. Inhibition of human cytochrome P450 enzymes by 1,2-dithiole-3-thione, oltipraz and its derivatives, and sulforaphane
18. Cytochrome P450TB (CYP2C): A major monooxygenase catalyzing diclofenac 4′-hydroxylation in human liver
19. Inactivation of cytochrome P450 2E1 by benzyl isothiocyanate
20. The carbon-monoxide binding pigment of liver microsomes
21. Suicidal destruction of cytochrome P-450 during oxidative drug metabolism
22. Drug metabolism by Escheriehia coli expressing human cytochromes P450
23. Cloning and isolation of human cytochrome P-450 cDNAs homologous to dioxin-inducible rabbit mRNAs encoding P-450 4 and P-450 6
24. Selective biotransformation of Taxol to 6α-hydroxytaxol by human cytochrome P450 2C8
25. Mechanistic studies of 9-ethynytphenanthrene-inactivated cytochrome P450 2B1
26. Monoamine oxidase-a inhibitors from medicinal plants
27. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1
28. Human liver microsomal cytochroree P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK 1002
29. Recombinant human cytochrome P450 1B1 expression in Escherichia coli
30. Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1
31. Oxyresveratrol as the potent inhibitor on dopa oxidase activity of mushroom tyrosinase
32. Inhibitory effects of hydroxystilbenes on cyclooxygenase from sheep seminal vesicles
33. In vitro methods for assessing human hepatic drug metabolism: Their use in drug development
34. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes
35. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes
36. Some properties of a detergent-solubilized NADPH-cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography
37. Modification of cytochrome P450 1A2 enzymes by the mechanism-based inactivator 2-ethynylnaphthalene and the photoaffinity label 4-azidobiphenyl
38. Comparative inhibition of human cytochromes P450 1A1 and 1A2 by flavonoids